Somewhat Favorable News Coverage Somewhat Unlikely to Affect Cardinal Health (CAH) Share Price
Media coverage about Cardinal Health (NYSE:CAH) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.2414864518389 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have effected Accern’s analysis:
- Head-To-Head Review: MWI Veterinary Supply (MWIV) & Cardinal Health (NYSE:CAH) (americanbankingnews.com)
- A Few Positives and Negatives For Cardinal Health, Inc. (CAH), Geron Corporation (GERN) – AllStockNews (allstocknews.com)
- Seth Klarman Bulks Up on Synchrony Despite Problems (finance.yahoo.com)
- Cardinal Health, Inc. :CAH-US: Earnings Analysis: 2017 By the Numbers : August 14, 2017 (finance.yahoo.com)
- Pharmerica Corporation (PMC) and Cardinal Health (CAH) Financial Review (americanbankingnews.com)
A number of equities research analysts recently weighed in on CAH shares. William Blair lowered shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 19th. Leerink Swann set a $72.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a report on Friday, April 21st. Barclays PLC restated an “overweight” rating and issued a $82.00 target price (down previously from $88.00) on shares of Cardinal Health in a report on Saturday, April 22nd. Cowen and Company lowered their target price on shares of Cardinal Health from $89.00 to $82.00 and set a “market perform” rating on the stock in a report on Tuesday, April 25th. Finally, Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $80.46.
Shares of Cardinal Health (NYSE:CAH) traded down 0.49% during midday trading on Tuesday, reaching $66.43. 2,004,008 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $74.93 and a 200-day moving average of $76.79. Cardinal Health has a 12-month low of $62.70 and a 12-month high of $84.88. The stock has a market capitalization of $20.99 billion, a P/E ratio of 16.48 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 earnings per share. Analysts anticipate that Cardinal Health will post $4.97 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date is Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.78%. Cardinal Health’s payout ratio is 45.79%.
TRADEMARK VIOLATION WARNING: This article was originally published by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.watchlistnews.com/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-cardinal-health-cah-share-price/1492497.html.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.